The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

If you’re retiring soon or know someone who is, you’re not alone. In 2024, a record 4.1 million Americans are expected to retire, with over 11,000 turning 65 every day. This phenomenon is sometimes re ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Medicare Advantage denials. Medicare Advantage plans, which are private insurance plans that contract with Medicare, denied 3 ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Rossen Reports looked at the FTC data so far in 2024. Read the full story here. Millions of us have memberships to wholesale ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...